Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Advanced Pharmaceutical Bulletin
ISSN: 2228-5881      eISSN: 2251-7308  
Services
Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks
Mendeley

Cite by
Google Scholar



Article History
Submitted: 13 May 2016
Revised: 13 Jul 2016
Accepted: 04 Aug 2016
First published online: 25 Sep 2016

Article Access Statistics
Abstract Page Views: 305
PDF Downloads: 171
Full Text Views: 0

Adv Pharm Bull. 2016;6(3):377-384 doi: 10.15171/apb.2016.049

Preliminary Safety Assessment of New Azinesulfonamide Analogs of Aripiprazole using Prokaryotic Models

Research Article

Beata Powroźnik 1, Karolina Słoczyńska 1, Krzysztof Marciniec 2, Paweł Zajdel 3, Elżbieta Pękala 1 *

1 Department of Pharmaceutical Biochemistry, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.
2 Department of Organic Chemistry, Medical University of Silesia, Jagiellońska 4, 41-200 Sosnowiec, Poland.
3 Department of Medicinal Chemistry, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.



Abstract

Purpose: Determination of the mutagenic potential of new biologically active compounds is of great concern for preliminary toxicity testing and drug development.

Methods: The mutagenic and antimutagenic effects of some quinoline- and isoquinoline-sulfonamide analogs of aripiprazole (1-8), which display potent antidepressant, anxiolytic, and antipsychotic properties, were evaluated using the Vibrio harveyi assay and OSIRIS Property Explorer software. Additionally, the Ames test was used as the reference.

Results: In silico prediction showed that compounds 5 (N-(3-(4-(2,3-dichlorophenyl)piperazin-1-yl)propyl)quinoline-7-sulfonamide) and 6 (N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)quinoline-7-sulfonamide) trigger a mutagenic structural alert. However, this was not confirmed by in vitro assays, as none of the tested compounds displayed mutagenic activity against all tested strains of bacteria. Moreover, compounds 1-8 displayed a protective effect against the mutagenicity induced by a direct acting mutagen NQNO. The most beneficial antimutagenic properties showed compound 5 which exhibited strong antimutagenic properties in all tested V. harveyi strains. High antimutagenic potency of this compound was confirmed in the Ames TA100 assay system.

Conclusion: Newly synthesized azinesulfonamide analogs of aripiprazole may be considered as genotoxically safe as they do not display mutagenic activity on the tester strains. Moreover, the tested compounds demonstrated significant antimutagenic properties that can be valuable for prevention of the NQNO genotoxicity. Additionally, it appears that the Vibrio harveyi assay can be applied for primary mutagenicity and antimutagenicity assessment of chemical substances, thus, representing a useful alternative tool for compounds safety evaluation.







Comments
First name  
Last name  
Email address  
Comments  
Security code



This Article
PDF

Google Scholar
Articles by Powroźnik B
Articles by Słoczyńska K
Articles by Marciniec K
Articles by Zajdel P
Articles by Pękala E

PubMed
Articles by Powroźnik B
Articles by Słoczyńska K
Articles by Marciniec K
Articles by Zajdel P
Articles by Pękala E



Share this article!

Press Manuscript Online. Powered by MAADRAYAN